Review of the Quality Use of Medicines Program's Delivery by the National Prescribing Service (NPS MedicineWise)

Closed 24 Jan 2019

Opened 7 Dec 2018

Feedback updated 26 May 2020

We asked

In December 2018, we asked for feedback based on the Terms of Reference for the Review of the Quality Use of Medicines Program’s delivery by the National Prescribing Service (NPS MedicineWise).

You said

54 external submissions were received and 26 external interviews were conducted. Submissions were detailed and highlighted the requirement for greater transparency, accountability and efficiency in the delivery of quality use of medicines programs. Thank you for this feedback.

We did

Emeritus Professor Lloyd Sansom AO conducted the Review and a final report has been accepted by Minister Hunt. The public report and the Government’s response to the Review recommendations can be found at

 We are working with NPS MedicineWise to implement the Review’s recommendations.  


The Department of Health (the Department) invites submissions to inform the Review of the Quality Use of Medicines Program's delivery by NPS MedicineWise (the Review).

The Review is being conducted by Emeritus Professor Lloyd Sansom AO.


The Australian Government funds the not-for-profit, NPS MedicineWise, to provide evidence based information, support tools and education services to health professionals and consumers to improve the quality use of medicines and diagnostic services in Australia.  

The Australian Government agreed through a 2018-19 Budget measure to undertake a review of NPS MedicineWise in regard to delivery of these government funded activities.

The Review Terms of Reference are attached.

Why your views matter

The purpose of this consultation is to seek broad stakeholder and community feedback to inform future Australian government policy settings for the delivery of the Quality Use of Medicines program.

Privacy Notification

The Department is bound by the Privacy Act 1988 and the Australian Privacy Principles (APPs).

The Department is collecting personal information about you in this consultation for the purposes of informing the Review.

The collection of this information is required to inform a review of the efficiency, effectiveness and appropriateness of the Australian Government funded Quality Use of Medicines program activities delivered by NPS MedicineWise.

While the Department encourages respondents to self-identify in their submission, there is no requirement to do so. However, if for example, should you choose to make an anonymous submission, the Department will be unable to attribute views to you in the Review Report (Report), or follow-up with you on any issues that you raise.

The Department will seek your permission before attributing your views in the Report.

The Australian Government may at its discretion share the Report or its findings with interested parties, including NPS MedicineWise.

The Department may disclose your responses to sub-contractors. Commonwealth contractors will be bound by the Privacy Act 1988.

The Department has an APP privacy policy which you can read at .  You can obtain a copy of the APP privacy policy by contacting the Department using the contact details set out at the end of this notice.  The APP privacy policy contains information about:

  • how you may access the personal information the Department holds about you and how you can seek correction of it; and
  • how you may complain about a breach of the APPs; or
  • a registered APP code that binds the Department; and
  • how the Department will deal with such a complaint.

You can contact the Department regarding its privacy policy by telephone on (02) 6289 1555 or freecall 1800 020 103 or by using the online enquiries form at

Making a Submission

Please email or mail submission by 5pm, Canberra local time, 24 January 2019 to or by mail to PO Box 9848, CANBERRA   ACT   2601.

If you wish to meet with the Review Team please email the request to by no later than 11 January 2019, and every effort will be made to accommodate your request either in person or teleconference.


  • Aboriginal and Torres Strait Islander People
  • Seniors
  • Men
  • Women
  • Carers and guardians
  • Families
  • Parents
  • Young people
  • Academics
  • Non-government organisations
  • State government agencies
  • Commonwealth agencies
  • Local governments
  • Health professionals
  • Health workforce
  • General public
  • Community groups
  • Businesses
  • Contracted Service Providers
  • Aged care service providers
  • BPRU staff
  • Graduates
  • Online and Publications staff
  • Secretariat
  • PCCD
  • Health staff
  • HPRG (TGA) Staff
  • Prescription medicines
  • Complementary medicines
  • Over-the-counter medicines
  • Medical Devices & IVDs
  • Biogicals
  • Other


  • Hospitals
  • e-Health
  • Health technology
  • Medicare
  • Pharmaceutical benefits
  • Rural health services
  • Regulatory policy
  • Women's health
  • Children's health
  • Learning and development
  • Aged Care
  • Alcohol
  • Tobacco
  • Chronic disease
  • Communicable diseases
  • Mental health
  • Drugs and substance abuse
  • Food standards
  • Organ and tissue donation
  • Immunisation
  • Hearing
  • Aboriginal and Torres Strait Islander health
  • Environmental health
  • Prescription drugs
  • Preventative health
  • Grants and procurement
  • Management review
  • Strategic Policy
  • Policy Development